Sten

Internationally Renowned Public Health Expert Sten Vermund Appointed President of the Global Virus Network (GVN)

Retrieved on: 
Thursday, November 2, 2023

BALTIMORE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN) today announced the appointment of Sten Vermund, MD, PhD , as President of the GVN.

Key Points: 
  • BALTIMORE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN) today announced the appointment of Sten Vermund, MD, PhD , as President of the GVN.
  • Lauder Professor of Public Health, former Dean of the Yale School of Public Health (2017-2022) and serves as a Professor in Pediatrics at the Yale School of Medicine.
  • Dr. Vermund transitions into his new role as Christian BrĂ©chot, MD, PhD, ends his second term as GVN President, becoming Vice Chairman of the GVN Board of Directors.
  • Dr. Vermund became increasingly engaged in health policy, particularly related to sustainability of HIV/AIDS programs and their expansion to non-communicable diseases, the coronavirus pandemic response and prevention, and public health workforce development.

Rebus Biosystems Appoints World-leading Researchers to Scientific Advisory Board

Retrieved on: 
Tuesday, November 2, 2021

Rebus Biosystems Inc. , (Rebus Bio, Rebus), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced that Drs.

Key Points: 
  • Rebus Biosystems Inc. , (Rebus Bio, Rebus), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced that Drs.
  • Arul Chinnaiyan, MD, PhD, and Sten Linnarsson, PhD, have been appointed to the Companys Scientific Advisory Board (SAB).
  • Were very proud to have Arul and Sten join the Rebus team, said Paul Sargeant, PhD, CEO of Rebus Biosystems.
  • Rebus Biosystems provides all-inclusive assay kits to empower researchers with the resolution, scale and speed of the Rebus Esper for multiple applications.